Excellence is not limited to our biopolymers — it extends to our entire industrial model, built on a state-of-the-art pharmaceutical-grade infrastructure. Designed to meet the highest standards of quality, safety, and consistency, it forms the foundation for building long-term partnerships with our clients, ensuring a consistent and secure supply aligned with their ambitions.
Located in Brittany, France, our industrial site covers more than 64,000 m², entirely dedicated to the innovation and development, production and quality control of pharmaceutical-grade biopolymers. From fermentation, extraction to purification, every step is rigorously controlled by experienced and passionate teams using cutting-edge technologies and processes.
To date, our site operates four independent production units:
To sustainably support the growth of our partners, we are expanding our site with:
Our industrial strategy is based on long-term reliability. Each investment is driven by a clear ambition: to provide our partners with optimal conditions to grow confidently, relying on the highest standards of pharmaceutical quality and supply security. With two independent production units for hyaluronic acid and polynucleotides, our production capacity is designed to achieve excellence while ensuring our customers’ peace of mind in the constantly evolving health and beauty sector.
Our mission goes beyond supplying biopolymers. We act as a true catalyst for innovation in medicine and biotechnology. Thanks to our industrial infrastructure and extensive expertise in pharmaceutical biopolymers, we empower health and beauty companies worldwide to bring their ambitions to life. From ophthalmology to aesthetics, and from rheumatology to regenerative medicine, our biopolymers are designed and manufactured to the highest standards, supporting safe, reliable, and sustainable innovation that benefits patients across the globe.
© 2025 Created by Zentrox Digital